These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 29028096)
1. Expressions of HIF-1α and KISS-1 in patients with liver cancer and correlation analysis. Song WW; Gui AP; Li W; Chen HS; Li JM Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4058-4063. PubMed ID: 29028096 [TBL] [Abstract][Full Text] [Related]
2. Expressions and correlation analysis of HIF-1α, survivin and VEGF in patients with hepatocarcinoma. Tian QG; Wu YT; Liu Y; Zhang J; Song ZQ; Gao WF; Guo TK; He CH; Dai FR Eur Rev Med Pharmacol Sci; 2018 Jun; 22(11):3378-3385. PubMed ID: 29917189 [TBL] [Abstract][Full Text] [Related]
3. Quantitative analysis of hepatic hypoxia-inducible factor-1alpha and its abnormal gene expression during the formation of hepatocellular carcinoma. Yao DF; Jiang H; Yao M; Li YM; Gu WJ; Shen YC; Qiu LW; Wu W; Wu XH; Sai WL Hepatobiliary Pancreat Dis Int; 2009 Aug; 8(4):407-13. PubMed ID: 19666411 [TBL] [Abstract][Full Text] [Related]
4. [Expressions of hepatitis B virus x protein and hypoxia-inducible factor-1alpha in hepatocellular carcinoma and their possible relationships]. Liu KG; Xie HH; Liu J Zhonghua Gan Zang Bing Za Zhi; 2007 Feb; 15(2):122-6. PubMed ID: 17362638 [TBL] [Abstract][Full Text] [Related]
5. The correlation of expression levels of HIF-1α and HIF-2α in hepatocellular carcinoma with capsular invasion, portal vein tumor thrombi and patients' clinical outcome. Yang SL; Liu LP; Jiang JX; Xiong ZF; He QJ; Wu C Jpn J Clin Oncol; 2014 Feb; 44(2):159-67. PubMed ID: 24374892 [TBL] [Abstract][Full Text] [Related]
6. [The prognostic significance of Omi/HtrA2 expression, and correlation between Omi/HtrA2 and hypoxia-inducible factor-1α in primary hepatocellular carcinoma cells]. Xu ZQ; Chen XP; Niu J; Liu EY; Li CH; Peng C Zhonghua Wai Ke Za Zhi; 2012 Jan; 50(1):49-52. PubMed ID: 22490291 [TBL] [Abstract][Full Text] [Related]
7. Regulation of COX-2 expression and epithelial-to-mesenchymal transition by hypoxia-inducible factor-1α is associated with poor prognosis in hepatocellular carcinoma patients post TACE surgery. Huang M; Wang L; Chen J; Bai M; Zhou C; Liu S; Lin Q Int J Oncol; 2016 May; 48(5):2144-54. PubMed ID: 26984380 [TBL] [Abstract][Full Text] [Related]
8. HIF-1α promoted vasculogenic mimicry formation in hepatocellular carcinoma through LOXL2 up-regulation in hypoxic tumor microenvironment. Wang M; Zhao X; Zhu D; Liu T; Liang X; Liu F; Zhang Y; Dong X; Sun B J Exp Clin Cancer Res; 2017 Apr; 36(1):60. PubMed ID: 28449718 [TBL] [Abstract][Full Text] [Related]
9. [Correlation of mRNA expression of hypoxia inducible factor-1alpha to biological features of pancreatic cancer]. Wei HY; Chen LB; Wang CY Ai Zheng; 2005 Feb; 24(2):184-8. PubMed ID: 15694030 [TBL] [Abstract][Full Text] [Related]
10. Involvement of hypoxia-inducible factor-1-alpha in multidrug resistance induced by hypoxia in HepG2 cells. Zhu H; Chen XP; Luo SF; Guan J; Zhang WG; Zhang BX J Exp Clin Cancer Res; 2005 Dec; 24(4):565-74. PubMed ID: 16471319 [TBL] [Abstract][Full Text] [Related]
11. Metformin suppresses hypoxia-induced stabilization of HIF-1α through reprogramming of oxygen metabolism in hepatocellular carcinoma. Zhou X; Chen J; Yi G; Deng M; Liu H; Liang M; Shi B; Fu X; Chen Y; Chen L; He Z; Wang J; Liu J Oncotarget; 2016 Jan; 7(1):873-84. PubMed ID: 26621849 [TBL] [Abstract][Full Text] [Related]
12. Transarterial embolization combined with RNA interference targeting hypoxia-inducible factor-1α for hepatocellular carcinoma: a preliminary study of rat model. Ni JY; Xu LF; Wang WD; Huang QS; Sun HL; Chen YT J Cancer Res Clin Oncol; 2017 Feb; 143(2):199-207. PubMed ID: 27638772 [TBL] [Abstract][Full Text] [Related]
13. SENP1 promotes hypoxia-induced cancer stemness by HIF-1α deSUMOylation and SENP1/HIF-1α positive feedback loop. Cui CP; Wong CC; Kai AK; Ho DW; Lau EY; Tsui YM; Chan LK; Cheung TT; Chok KS; Chan ACY; Lo RC; Lee JM; Lee TK; Ng IOL Gut; 2017 Dec; 66(12):2149-2159. PubMed ID: 28258134 [TBL] [Abstract][Full Text] [Related]
14. Mitochondrial dysfunction represses HIF-1α protein synthesis through AMPK activation in human hepatoma HepG2 cells. Hsu CC; Wang CH; Wu LC; Hsia CY; Chi CW; Yin PH; Chang CJ; Sung MT; Wei YH; Lu SH; Lee HC Biochim Biophys Acta; 2013 Oct; 1830(10):4743-51. PubMed ID: 23791554 [TBL] [Abstract][Full Text] [Related]
15. Expression and significance of hypoxia-inducible factor-1α and survivin in laryngeal carcinoma tissue and cells. Li DW; Zhou L; Jin B; Xie J; Dong P Otolaryngol Head Neck Surg; 2013 Jan; 148(1):75-81. PubMed ID: 23087365 [TBL] [Abstract][Full Text] [Related]
16. The TNF-α/ROS/HIF-1-induced upregulation of FoxMI expression promotes HCC proliferation and resistance to apoptosis. Xia L; Mo P; Huang W; Zhang L; Wang Y; Zhu H; Tian D; Liu J; Chen Z; Zhang Y; Chen Z; Hu H; Fan D; Nie Y; Wu K Carcinogenesis; 2012 Nov; 33(11):2250-9. PubMed ID: 22831955 [TBL] [Abstract][Full Text] [Related]
17. Wnt/β-catenin signaling enhances hypoxia-induced epithelial-mesenchymal transition in hepatocellular carcinoma via crosstalk with hif-1α signaling. Zhang Q; Bai X; Chen W; Ma T; Hu Q; Liang C; Xie S; Chen C; Hu L; Xu S; Liang T Carcinogenesis; 2013 May; 34(5):962-73. PubMed ID: 23358852 [TBL] [Abstract][Full Text] [Related]
18. Correlations between ADC values and molecular markers of Ki-67 and HIF-1α in hepatocellular carcinoma. Huang Z; Xu X; Meng X; Hou Z; Liu F; Hua Q; Liu Q; Xiu J Eur J Radiol; 2015 Dec; 84(12):2464-9. PubMed ID: 26456310 [TBL] [Abstract][Full Text] [Related]
19. Hypoxia-independent overexpression of hypoxia-inducible factor 1alpha as an early change in mouse hepatocarcinogenesis. Tanaka H; Yamamoto M; Hashimoto N; Miyakoshi M; Tamakawa S; Yoshie M; Tokusashi Y; Yokoyama K; Yaginuma Y; Ogawa K Cancer Res; 2006 Dec; 66(23):11263-70. PubMed ID: 17145871 [TBL] [Abstract][Full Text] [Related]
20. Increased expression of PHD3 represses the HIF-1 signaling pathway and contributes to poor neovascularization in pancreatic ductal adenocarcinoma. Tanaka T; Li TS; Urata Y; Goto S; Ono Y; Kawakatsu M; Matsushima H; Hirabaru M; Adachi T; Kitasato A; Takatsuki M; Kuroki T; Eguchi S J Gastroenterol; 2015 Sep; 50(9):975-83. PubMed ID: 25542265 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]